Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
69 participants
OBSERVATIONAL
2015-06-30
2019-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sex Differences in Vascular Responses to Exercise
NCT04128215
Exercise Frequency During Endurance Training: Cardiorespiratory, Hematological, and Muscle Oxidative Adaptations
NCT05908578
Effect of Aerobic Interval Training on Cardiovascular Function in Aging
NCT01883271
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
NCT05712395
Vascular Responses to High vs Low Repetition Resistance Exercise Training in Young Men
NCT02842593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Slow-paced walking
Subjects will complete 47 minutes of walking at slow pace.
Slow-paced walking
Subjects will complete 47 minutes of walking on a treadmill at a slow-pace.
Treadmill
Moderate-paced walking
Subjects will complete 47 minutes of walking at a moderate pace.
Moderate-paced walking
Subjects will complete 47 minutes of walking on a treadmill at a moderate pace.
Treadmill
Interval training
Subjects will complete 40 minutes of walking alternating between a moderate and fast pace.
Interval Training
Subjects will complete 40 minutes of walking on the treadmill alternating between a moderate and a fast pace.
Treadmill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Slow-paced walking
Subjects will complete 47 minutes of walking on a treadmill at a slow-pace.
Moderate-paced walking
Subjects will complete 47 minutes of walking on a treadmill at a moderate pace.
Interval Training
Subjects will complete 40 minutes of walking on the treadmill alternating between a moderate and a fast pace.
Treadmill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women will be premenopausal or postmenopausal (either natural or surgical) defined as a cessation of menses for at least 2 years.
* Premenopausal women will be eumenorrheic.
* Able to give consent.
Exclusion Criteria
* History of other relevant on-going or recurrent illness
* Recent (within 3 months) or recurrent hospitalizations
* Current intake of medications that may affect study results
* Use of tobacco products
* Premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy.
* Pregnancy (positive urine pregnancy test) or lactation
* Perimenopausal women
18 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Demetra Christou, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integrative Cardiovascular Physiology Laboratory
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB201401078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.